About the Sinovac, Sputnik V and Johnson & Johnson Covid-19 vaccines


An inactivated adenovirus is used as the vector to deliver the gene for the SARS-CoV-2 spike protein into the body in the Sinovac, Sputnik V, and Johnson and Johnson Covid-19 vaccines. — Wikimedia Commons

The efficacy of the Sinovac vaccine (officially named CoronaVac, but more popularly known by the name of its developer Beijing-based biopharmaceutical company Sinovac Biotech Limited) has been found to be to be 50.4% in preventing symptomatic Covid-19 by researchers in Brazil.

The director of the Chinese Center for Disease Control and Prevention himself has said that “Chinese vaccines don’t have very high protection rates”, and that the Chinese government is considering mixing the vaccines to give their efficacy a boost.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Health

Faking symptoms to get antibiotics
Premature babies: Their fight to survive�
Diabetic retinopathy: When diabetes steals your sight
Plant proteins can help boost testosterone
How industry players influence government regulators�
When your brain won't let you fall sleep
Dispensing drugs to the disabled
One in four teens not getting enough physical activity
For babies, it's back to sleep, tummy to play�
Circadian depression:�When body clock disruptions affect the mind

Air Pollutant Index

Note: API is calculated based on 24hr running average of the most dominant parameter.

Highest API Readings

    Select State and Location to view the latest API reading

    Others Also Read